Brainify.AI Email Format
Mental Health CareNew York, United States11-50 Employees
Brainify.AI, based in New York City, operates an AI-driven biomarker platform aimed at accelerating the development of novel depression treatments. The platform seeks to improve both the chances of regulatory approval and the efficacy of new therapies. It targets researchers and pharmaceutical developers working on depression therapeutics. The company sits within the mental health care field, applying AI to biomarker work related to depression. It has engaged in industry partnerships, including a collaboration with Clerkenwell Health. In 2025, Brainify.AI received an Honorable Mention in the Biotech category at the Nebius AI Discovery Awards.